THERATEST LAB, INC., EL-ANASCR KIT

Antinuclear Antibody (enzyme-labeled), Antigen, Controls

THERATEST LABORATORIES, INC.

The following data is part of a premarket notification filed by Theratest Laboratories, Inc. with the FDA for Theratest Lab, Inc., El-anascr Kit.

Pre-market Notification Details

Device IDK954106
510k NumberK954106
Device Name:THERATEST LAB, INC., EL-ANASCR KIT
ClassificationAntinuclear Antibody (enzyme-labeled), Antigen, Controls
Applicant THERATEST LABORATORIES, INC. 2201 WEST CAMPBELL PARK DR. Chicago,  IL  60612 -3501
ContactMarius Teodorescu
CorrespondentMarius Teodorescu
THERATEST LABORATORIES, INC. 2201 WEST CAMPBELL PARK DR. Chicago,  IL  60612 -3501
Product CodeLJM  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1995-08-01
Decision Date1995-11-14

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00854473003057 K954106 000
00854473003002 K954106 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.